Remove Big Data Remove Clinical Research Remove Engineer Remove Genomics
article thumbnail

The future of AI drug discovery & development in immunology and GPCR research

pharmaphorum

Verily’s Immune Profiler platform is “a discovery engine consisting of proprietary immune profiling lab workflow, growing multi-omic database, and advanced analytical tools”. A notable issue with clinical trials is the homogeneity of the patient database. What, then, is the solution? About the interviewee.

article thumbnail

How big data analytics can make personalised care a reality

Drug Discovery World

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The rise of real-world evidence: unlocking the potential in EHRs

pharmaphorum

International deep real-world evidence company Savana is on a mission to give health researchers the power to unlock the clinical value embedded within electronic health records (EHRs) using artificial intelligence (AI) and clinical Natural Language Processing (NLP) techniques.

Doctors 116
article thumbnail

Syntegra Partnering with National Institutes of Health (NIH) and the Bill and Melinda Gates Foundation to Democratize Access to the Largest Set of COVID-19 Patient Records

The Pharma Data

18, 2021 /PRNewswire/ — Today Syntegra and the National Institutes of Health (NIH) have announced a collaboration to validate Syntegra’s AI-enabled synthetic data technology to advance the understanding of and care for COVID-19. rows of data. rows of data. . SAN FRANCISCO , Jan. .